Clinical Trials
Showing 1-10 results of 19 total
Cancer
New study for men with high-risk prostate cancer with a known BRCA mutation.
This study will compare an investigational drug (saruparib [AZD5305]) versus placebo, added to a standard radiotherapy/androgen deprivation therapy (ADT)...
Cancer|Gynecology and Obstetrics
New investigational drug for treatment of platinum-resistant ovarian cancer
This study will evaluate the safety and effectiveness of investigational oral drug INCB123667 in patients with platinum-resistant ovarian, fallopian tube, or...
Cancer|Gastroenterology
Investigational drug for metastatic pancreatic ductal adenocarcinoma
This study will evaluate the safety and effectiveness of investigational oral drug BMS-986504 in combination with standard chemotherapy in patients with...
Cancer|Gynecology and Obstetrics
New study for Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer
This study will evaluate the safety and effectiveness of carboplatin + Mirvetuximab Soravtansine (MIRV). Subjects will receive up to 6 cycles of carboplatin...
Cancer|Gynecology and Obstetrics
New investigational drug for endometrial cancer
The purpose of this study is to evaluate the safety and effectiveness of investigational drug AZD8205 in comparison to standard of care treatment for...
Cancer
A Research Study of OBI-902 in Participants with Advanced Solid Tumors.
This study will evaluate the safety and tolerability of investigational drug OBI-902 in participants with advanced solid tumors. The study also aims to find...
Cancer
New study for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
This study will compare the medication Sonrotoclax plus an anti-CD20 antibody therapy versus Venetoclax plus Rituximab. Enrollment into the different study...
Cancer
New study for patients with HR+ HER2- advanced breast cancer
This is a double-blind, placebo-controlled study evaluating the efficacy and safety of Inavolisib + a CDK4/6 inhibitor and letrozole, versus placebo + a...
Cancer
New investigational drug for treatment of ovarian cancer
This study will test the safety and effectiveness of an investigational drug combined with an FDA approved dose of Bevacuzimab for ovarian cancer....
Cancer
Investigational drug for breast cancer patients with brain metastases
The purpose of this study is to evaluate the safety and effectiveness of investigational drug UTD1 in combination with approved capecitabine in the treatment...